secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001104659-24-086824
Event type: other_material
Sentiment:  negative
Materiality: 0.95
Item codes: 2.04, 3.01, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics faces $7M debt acceleration, board resignations, workforce cuts, R&D pause
--------------------------------------------------------------------------------

- ImmunogenX subsidiary received default notice accelerating $6,997,583 in obligations under Credit Agreement.
- Directors Charles Casamento and Terry Coelho resigned Aug 2; audit committee now non-compliant with Nasdaq Rule 5605(c)(2).
- CEO James Sapirstein and President Jack Syage terminated; Sapirstein becomes consultant at $400/hour for 6 months.
- Company terminated all non-essential employees, vacated Boca Raton office, and paused non-essential R&D activities.
- Exploring strategic alternatives including capital raising, restructuring debt, and other options to maximize stakeholder value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924086824/0001104659-24-086824-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924086824/tm2421105d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-086824

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer